MitoPower is a biopharmaceutical company established to develop novel therapies to treat disorders associated with mitochondrial dysfunction. MitoPower maintains numerous academic collaborations in the context of energy metabolism, liver biology and immune function. It has working relationships with world-class CROs in pharmaceutical development, pre-clinical pharmacology, and toxicology. MitoPower’s leadership team has deep experience in drug development in the field of liver diseases, including expertise in medicinal chemistry, pharmacology, toxicology, and regulatory matters.
Company Details
- Employees
- 3
- Founded
- 2017
- Address
- Palo Alto, California, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.mitopower.com
- Keywords
- New York.
- HQ
- Palo Alto, California
Mitopower Questions
Mitopower's website is https://www.mitopower.com
Mitopower's LinkedIn profile is https://www.linkedin.com/company/mitopower
Mitopower has
3 employees.
View email and phone details for 3
employees at Mitopower.
Mitopower's industry is
Biotechnology Research
Mitopower's top competitors are
Truelaw (A Consilio Company),
Adamas Pharmaceuticals, Inc.,
Your Choice Therapy,
Nuevabio,
Orsobio,
Zoho,
Data Glacier,
Indiamart Intermesh Limited,
Triesta Sciences,
Kpmg India.
Mitopower's categories are Biotechnology Research
Mitopower's founding year is 2017
